Secondary mutations in BRCA2 associated with clinical resistance to a PARP inhibitor.
Barber LJ, Sandhu S, Chen L, Campbell J, Kozarewa I, Fenwick K, Assiotis I, Rodrigues DN, Reis Filho JS, Moreno V, Mateo J, Molife LR, De Bono J, Kaye S, Lord CJ, Ashworth A.
Barber LJ, et al. Among authors: de bono j.
J Pathol. 2013 Feb;229(3):422-9. doi: 10.1002/path.4140.
J Pathol. 2013.
PMID: 23165508